Cargando…

Parvovirus-Based Combinatorial Immunotherapy: A Reinforced Therapeutic Strategy against Poor-Prognosis Solid Cancers

SIMPLE SUMMARY: Oncolytic virotherapy using oncolytic viruses with natural or engineered cancer-destroying capacities has emerged as a promising treatment concept in modern oncology. Rodent protoparvoviruses, in particular the rat H-1 parvovirus (H-1PV), have demonstrated their broad-range tumor-sup...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelova, Assia, Ferreira, Tiago, Bretscher, Clemens, Rommelaere, Jean, Marchini, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832409/ https://www.ncbi.nlm.nih.gov/pubmed/33477757 http://dx.doi.org/10.3390/cancers13020342

Ejemplares similares

Oncolytic parvoviruses: from basic virology to clinical applications
por: Marchini, Antonio, et al.
Publicado: (2015)

The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers
por: Angelova, Assia L., et al.
Publicado: (2017)

Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients
por: Angelova, Assia L., et al.
Publicado: (2015)

Oncolytic H-1 Parvovirus Enters Cancer Cells through Clathrin-Mediated Endocytosis
por: Ferreira, Tiago, et al.
Publicado: (2020)

H-1 Parvovirus as a Cancer-Killing Agent: Past, Present, and Future
por: Bretscher, Clemens, et al.
Publicado: (2019)

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
por: Angelova, Assia L., et al.
Publicado: (2017)

Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study
por: Marchini, Antonio, et al.
Publicado: (2019)

Oncolytic H-1 Parvovirus Hijacks Galectin-1 to Enter Cancer Cells
por: Ferreira, Tiago, et al.
Publicado: (2022)

Generation and Validation of Monoclonal Antibodies Suitable for Detecting and Monitoring Parvovirus Infections
por: Tessmer, Claudia, et al.
Publicado: (2022)

Immune System Stimulation by Oncolytic Rodent Protoparvoviruses
por: Angelova, Assia, et al.
Publicado: (2019)

Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
por: Kulkarni, Amit, et al.
Publicado: (2021)

Parvoviruses-tools to fine-tune anticancer immune responses
por: Grekova, Svitlana P., et al.
Publicado: (2012)

An “eat me” combinatory nano-formulation for systemic immunotherapy of solid tumors
por: Abdel-Bar, Hend Mohamed, et al.
Publicado: (2021)

Vesicular Egress of Non-Enveloped Lytic Parvoviruses Depends on Gelsolin Functioning
por: Bär, Séverine, et al.
Publicado: (2008)

Vesicular Transport of Progeny Parvovirus Particles through ER and Golgi Regulates Maturation and Cytolysis
por: Bär, Séverine, et al.
Publicado: (2013)

NK-cell-dependent killing of colon carcinoma cells is mediated by natural cytotoxicity receptors (NCRs) and stimulated by parvovirus infection of target cells
por: Bhat, Rauf, et al.
Publicado: (2013)

Oncolytic Virotherapy as Emerging Immunotherapeutic Modality: Potential of Parvovirus H-1
por: Moehler, Markus, et al.
Publicado: (2014)

Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas
por: Li, Junwei, et al.
Publicado: (2013)

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
por: Geletneky, Karsten, et al.
Publicado: (2017)

The XVIII International Parvovirus Workshop Rimini, Italy, 14–17 June 2022
por: Gallinella, Giorgio, et al.
Publicado: (2023)

A novel scalable, robust downstream process for oncolytic rat parvovirus: isoelectric point-based elimination of empty particles
por: Leuchs, Barbara, et al.
Publicado: (2017)

Combinatorial Immunotherapies for Metastatic Colorectal Cancer
por: Janssen, Eline, et al.
Publicado: (2020)

PKCη/Rdx-driven Phosphorylation of PDK1: A Novel Mechanism Promoting Cancer Cell Survival and Permissiveness for Parvovirus-induced Lysis
por: Bär, Séverine, et al.
Publicado: (2015)

Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune Silencing
por: Goepfert, Katrin, et al.
Publicado: (2019)

Improved Killing of Human High-Grade Glioma Cells by Combining Ionizing Radiation with Oncolytic Parvovirus H-1 Infection
por: Geletneky, Karsten, et al.
Publicado: (2010)

Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1
por: Moehler, Markus, et al.
Publicado: (2011)

Ozone therapy: protocol for treating canine parvovirus infection
por: dos Santos, Tiago Gonçalves, et al.
Publicado: (2023)

Parvoviruses
por: O. Jacoby, Robert, et al.
Publicado: (2007)

Parvovirus
por: Green, Linda K., et al.
Publicado: (2013)

Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
por: Marchini, Antonio, et al.
Publicado: (2016)

Preclinical Testing of an Oncolytic Parvovirus: Standard Protoparvovirus H-1PV Efficiently Induces Osteosarcoma Cell Lysis In Vitro
por: Geiss, Carsten, et al.
Publicado: (2017)

The Problem of Host and Pathogen Genetic Variability for Developing Strategies of Universally Efficacious Vaccination against and Personalised Immunotherapy of Tuberculosis: Potential Solutions?
por: Bretscher, Peter A.
Publicado: (2023)

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
por: Economopoulou, Panagiota, et al.
Publicado: (2017)

Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells
por: Angelova, Assia, et al.
Publicado: (2023)

Biology of Porcine Parvovirus (Ungulate parvovirus 1)
por: Mészáros, István, et al.
Publicado: (2017)

Effective Combinatorial Immunotherapy for Castration Resistant Prostate Cancer
por: Lu, Xin, et al.
Publicado: (2017)

Effective combinatorial immunotherapy for penile squamous cell carcinoma
por: Huang, Tianhe, et al.
Publicado: (2020)

Oncolytic effects of parvovirus H-1 in medulloblastoma are associated with repression of master regulators of early neurogenesis
por: Lacroix, Jeannine, et al.
Publicado: (2014)

Activation of a Helper and Not Regulatory Human CD4+ T Cell Response by Oncolytic H-1 Parvovirus
por: Moralès, Olivier, et al.
Publicado: (2012)

A drug screening to identify novel combinatorial strategies for boosting cancer immunotherapy efficacy
por: Zhang, Zongliang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fk258ooo1vund1ae9fomhurksp